The Spa at Norwich Inn in Norwich, Connecticut, offers various programs for health and wellness, and I went there wondering what services it could provide for clients with diabetes.
Data from two new studies shows patients with type 2 diabetes starting insulin therapy had a 43% lower rate of night-time hypoglycemia when using degludec, Novo Nordisk’s ultra-long-acting insulin, compared with those using insulin glargine (Lantus).
Incidence of type 1 diabetes is increasing and the disease is presenting at earlier ages. Each year, in the U.S. alone, approximately 15,000 children and adolescents are diagnosed with type 1 diabetes. It is one of the most common chronic diseases in school-aged children.
Yesterday I told Jessica that I felt a little like someone with type 2 diabetes. My numbers rarely go over 200 and I haven’t had any episodes of severe…
The Japanese Ministry of Health, Labour and Welfare has approved Novo Nordisk's ultra-long acting insulin, insulin degludec, for treatment of diabetes.
Insulin degludec, marketed globally under the name Tresiba, is a new generation of once-daily basal insulin, which has been discovered and developed by Novo Nordisk.
If you want to know what it would feel like if the world stopped for a day, you should come to Tel Aviv for Yom Kippur. On this holiday, the day of atonement,…
Even if I tested every hour it wouldn’t guarantee perfection. Sometimes I have to remind myself that a blood sugar of 147 is just a moment. It doesn’t make me a criminal.